40 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
12852763	20	Computer-aided selection of potential antihypertensive compounds with dual mechanism of action.	Institute Of Biomedical Chemistry Of Russian Academy Of Medical Sciences
10669576	65	Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action.	Novartis Institute For Biomedical Research
10669559	180	Protease inhibitors: current status and future prospects.	University Of Queensland
10882358	62	Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents.	F. Hoffmann-La Roche
8544178	46	New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.	Ciba-Geigy
8120868	22	N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitors.	Ciba-Geigy
8254611	12	Design and synthesis of an orally active macrocyclic neutral endopeptidase 24.11 inhibitor.	Ciba-Geigy
2585440	34	Enkephalinase inhibitors. 1. 2,4-Dibenzylglutaric acid derivatives.	Ciba-Geigy
2993614	21	Synthesis and biological evaluation of phosphonamidate peptide inhibitors of enkephalinase and angiotensin-converting enzyme.	TBA
3897541	27	New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.	TBA
	22	Design and synthesis of phosphinic acids that triply inhibit endothelin converting enzyme, angiotensin converting enzyme and neutral endopeptidase 24.11	TBA
	18	Highly potent and selective inhibitors of endothelin converting enzyme	TBA
	21	Potent inhibitors of neutral endopeptidase. 2-Biphenyl- methylglutaric acid amide derivatives	TBA
	20	4-Substituted proline derivatives that inhibit angiotensin converting enzyme and neutral endopeptidase 24.11.	TBA
	46	Mercaptoacyl dipeptides as dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Preliminary structure-activity studies	TBA
	20	Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon	TBA
	3	The synthesis of aminobenzazepinones as anti-phenylalanine dipeptide mimics and their use in nep inhibition	TBA
	5	Design and synthesis of a new class of conformationally constrained inhibitors to probe the active sites of thermolysine and neutral endopeptidase 24.11	TBA
	16	Synthesis of constrained thiorphan analogs as inhibitors of neutral endopeptidase	TBA
	28	α-Mercaptoacyl dipeptides that inhibit angiotensin converting enzyme and neutral endopeptidase 24.11	TBA
	3	Non-peptidic inhibitors of neutral endopeptidase 24.11 2. Design and pharmacology of orally active phosphonate prodrugs	TBA
	26	Non-peptidic inhibitors of neutral endopeptidase 24.11 1. Discovery and optimization of potency	TBA
	6	The effect of heteroatom substitution on a series of phosphonate inhibitors of neutral endopeptidase 24.11	TBA
	6	Gem-cycloalkyl substituted thiol inhibitors of neutral endopeptidase 24.11. Synthesis via nucleophilic opening of 2,2-spiro-β-lactones	TBA
17070062	16	Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder.	Pfizer
16821800	96	Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramides.	Pfizer
10698448	24	N-formyl hydroxylamine containing dipeptides: generation of a new class of vasopeptidase inhibitors.	Bristol-Myers Squibb Pharmaceutical Research Institute
9925736	16	Vasopeptidase inhibitors: incorporation of geminal and spirocyclic substituted azepinones in mercaptoacyl dipeptides.	The Bristol-Myers Squibb Pharmaceutical Research Institute
9484512	130	Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.	Shionogi
8558518	38	Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.	Bristol-Myers Squibb Pharmaceutical Research Institute
8496905	6	Synthesis and analgesic effects of N-[3-[(hydroxyamino) carbonyl]-1-oxo-2(R)-benzylpropyl]-L-isoleucyl-L-leucine, a new potent inhibitor of multiple neurotensin/neuromedin N degrading enzymes.	Ccipe-Faculté
8360888	14	Application of a conformationally restricted Phe-Leu dipeptide mimetic to the design of a combined inhibitor of angiotensin I-converting enzyme and neutral endopeptidase 24.11.	Marion Merrell Dow Research Institute
8254612	10	Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors.	Ciba-Geigy
7752193	43	Dicarboxylic acid dipeptide neutral endopeptidase inhibitors.	Ciba-Geigy
3517331	10	1H NMR configurational correlation for retro-inverso dipeptides: application to the determination of the absolute configuration of"enkephalinase" inhibitors. Relationships between stereochemistry and enzyme recognition.	TBA
1738153	45	A novel class of enkephalinase inhibitors containing a C-terminal sulfo group.	Dainippon Pharmaceutical